Daily Newsletter

31 August 2023

Daily Newsletter

31 August 2023

Over 400 Irish hospital consultants accept new public-only contracts

The contracts offer salaries up to €252,000 and bar consultants from conducting private work at public hospitals.

August 31 2023

More than 400 hospital consultants in Ireland have accepted new public-only contracts, with 294 existing consultants transitioning from their previous contracts and 125 newly appointed consultants joining, reported The Irish Times.

Despite being dismissed by the Irish Medical Organisation (IMO) and Irish Hospital Consultants’ Association (IHCA), the new contracts were introduced in March by the government.

The contracts offer salaries up to €252,000, and bar consultants from conducting private work in public hospitals.

Including further allowances, overtime payments and pension contributions, the packages are worth up to €300,000.

While the Health Service Executive (HSE) has seen a steady increase in sign-ups, concerns remain about issues such as working hours, locations, and resources.

IMO welcomed the move but highlighted that it's a fraction of the number required to fill the 900-plus vacant consultant roles in the health industry.

IMO consultant committee chair Matthew Sadlier was quoted as saying by the publication: “We are short a further 2,000 consultants based on population at the moment so the scale of the challenge is clear.”

While existing consultants can stay on their old contracts, new consultants must work under the new terms.

An HSE spokesman stated: “The new contract has significant benefits for the health services in terms of the flexibilities contained therein and also an attractive remuneration package for the individuals."

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close